Pooled serum containing 750 µg of total IgG (quantified by IgG ELISA, Invitrogen, Carlsbad, CA) harvested from intramuscularly ΔgD-2 or control (VD60) vaccinated C57Bl/6 mice was inoculated intraperitoneally into naïve WT or C1q-knockout BL/6 mice 24 h prior to skin challenge with HSV-2(4674) (5 × 10 PFU/mouse [13] ), as previously described [18]. Mice were then monitored daily for epithelial and neurological disease and scored as follows: (1) erythema at inoculation site; (2) spread to distant site, zosteriform lesions, edema; (3) ulcerations, epidermal spread, limb paresis; (4) hind limb paralysis and (5) death. Mice were euthanized at a score of 4 and assigned a score of 5 the following day. At the time of euthanasia (when mice succumbed or day 14 post-challenge), sacral nerve tissue was collected and DNA isolated using the Qiagen Blood and Tissue DNA isolation kit (Qiagen, Hilden, Germany). A total of 10 ng of DNA per sample was loaded, and primers and probes specific for HSV polymerase were used to quantify HSV DNA (forward primer sequence, 5′-GGCCAGGCGCTTGTTGGTGTA-3′; reverse primer sequence, 5′-ATCACCGACCCGGAGAGGGA-3′; probe sequence, 5′-CCGCCGAACTGAGCAGACACCCGC-3′). Mouse β actin was used as a loading control (Applied Biosystems, Foster City, CA, USA), and qPCR was run in an Applied Biosystems QuantStudio 7 Flex.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.